Phase I trial of CF 101.
Phase of Trial: Phase I
Latest Information Update: 10 May 2013
At a glance
- Drugs Piclidenoson (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 10 May 2013 Status changed from not yet recruiting to completed, as reported in a Seikagaku Corporation media release.
- 20 Aug 2008 New trial record.